:

Homeland Security

NIAID Issues BAA for Bio-Defense Vaccine Enhancement

DDN

Wednesday, October 3rd, 2007

SHARE:

The National Institute of Allergy and Infectious Diseases (NIAID), with funding provided in whole or in part by the Biomedical Advanced Research and Development Agency, plans to fund organizations with demonstrated vaccine product development experience to produce a vaccine candidate either for a NIAID Category A or B Priority Pathogen or a candidate third generation anthrax vaccine. Sol. No. BAA-NIH-BARDA-NIAID-DMID-AI2007007. Respond by Jan. 22, 2008. Contact: Jordan Pulaski, contract specialist, 301-451-480-4675, jpulaski@niaid.nih.gov.

Congress

SASC Cites Concern With Army’s sUAS Approach, Seeks Info On Plans To Scale Fielding

Senate defense authorizers are seeking more info from the Army on its plans for scaling and deploying small drone capabilities citing concern with the service’s current “fragmented and insufficient” approach. […]

SASC Bill Would Raise Amphib Requirement To 33 Ships

The Senate Armed Services Committee’s (SASC) fiscal year 2027 defense policy bill adds new provisions that would raise the Navy and Marine Corps’ minimum requirement for amphibious warships and extend […]

Army

Army Plans To Initiate ISV-Heavy Competition Later This Year, Official Says

The Army is planning to initiate its competition to build the Infantry Squad Vehicle (ISV)-Heavy in the fourth quarter of this year, a senior acquisition official has said. Jesse Tolleson, […]

Senate Authorization Bill Restricts Building Navy Warships Overseas With Limited Exception For Auxiliaries

The Senate Armed Services Committee’s (SASC) version of the FY 2027 defense policy bill looks to cut the ability for the Trump administration to buy foreign-made warships, but still allow […]